Your about to leave the site and are being redirected to another site. Would you like to leave this site?




BAVENCIO is a prescription medicine used to treat a type of cancer in the bladder or urinary tract called urothelial cancer. BAVENCIO may be used when your cancer:
  • Has spread and cannot be removed by surgery (advanced urothelial cancer), and 
  • You have received chemotherapy that contains a platinum-containing drug and it did not work or is no longer working


This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials.

It is not known if BAVENCIO is safe and effective in children under the age of 12.

Visit to learn about patient access and reimbursement support for BAVENCIO—or call 844-8COVER1